The Cancer Research Institute received a very special holiday treat this morning, with a prominent mention at the end of a short NPR radio podcast about the origins of cancer immunotherapy. The six-and-one-half-minute story focuses on the work of late 19th-century surgeon Dr. William B. Coley, who was the first to develop an immunotherapy-based treatment, called Coley’s Toxins, for non-operable tumors.
His daughter, Helen Coley Nauts, followed up on her father’s work and founded the Cancer Research Institute in 1953 to continue exploring the link between the immune system and cancer, "a dedication that has been key in making immunotherapy the promising treatment it is today."
I recommend that you listen to the story below. You can also read a slightly different version on the NPR website.
Top 5 Cancer Immunotherapy Stories of 2015
Read Previous Article
William Coley and Cancer Immunotherapy Spotlighted on NPR
Read Next Article
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
Immunotherapy clinical trials are critical endeavors that lead to breakthrough cancer treatments.
This Skin Cancer Awareness month, discover new research, treatments, and progress for a future immune to skin cancer.